Atlas Trials

Study of Pegylated Human Recombinant Arginase for Liver Cancer

Clinical trial NCT00988195 · COMPLETED

Trial details

NCT number
NCT00988195
Sponsor
Bio-Cancer Treatment International Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
NeoplasmHepatocellular Carcinoma
Start date
2008-05-01
Primary completion
2009-08-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.